Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Olaparib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lynparza 100mg tablets
0801050BYBBABAB
|
Lynparza | Olaparib | Malignant Disease and Immunosuppression | No data available |
|
Lynparza 150mg tablets
0801050BYBBACAC
|
Lynparza | Olaparib | Malignant Disease and Immunosuppression | No data available |
|
Lynparza 50mg capsules
0801050BYBBAAAA
|
Lynparza | Olaparib | Malignant Disease and Immunosuppression | No data available |
|
Olaparib 100mg tablets
0801050BYAAABAB
|
Olaparib | Olaparib | Malignant Disease and Immunosuppression | No data available |
|
Olaparib 150mg tablets
0801050BYAAACAC
|
Olaparib | Olaparib | Malignant Disease and Immunosuppression | No data available |
|
Olaparib 50mg capsules
0801050BYAAAAAA
|
Olaparib | Olaparib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.